| 1 |
34965924 | Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes. | 2022 Apr |
2 |
| 2 |
34973477 | LKB1 in Intestinal Epithelial Cells Regulates Bile Acid Metabolism by Modulating FGF15/19 Production. | 2022 |
3 |
| 3 |
35105957 | Transcription factor Klf9 controls bile acid reabsorption and enterohepatic circulation in mice via promoting intestinal Asbt expression. | 2022 Feb 1 |
2 |
| 4 |
35133032 | TCF7L2 transcriptionally regulates Fgf15 to maintain bile acid and lipid homeostasis through gut-liver crosstalk. | 2022 Mar |
3 |
| 5 |
35462858 | Differential and organ-specific functions of organic solute transporter α and β in experimental cholestasis. | 2022 May |
1 |
| 6 |
35500802 | Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice. | 2022 Aug 10 |
2 |
| 7 |
32198567 | Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation. | 2021 Feb |
2 |
| 8 |
33127558 | Hepatic Autophagy Deficiency Remodels Gut Microbiota for Adaptive Protection via FGF15-FGFR4 Signaling. | 2021 |
1 |
| 9 |
33154041 | Regulation of Intestinal UDP-Glucuronosyltransferase 1A1 by the Farnesoid X Receptor Agonist Obeticholic Acid Is Controlled by Constitutive Androstane Receptor through Intestinal Maturation. | 2021 Jan |
1 |
| 10 |
33484478 | Monomeric/dimeric forms of Fgf15/FGF19 show differential activity in hepatocyte proliferation and metabolic function. | 2021 Feb |
4 |
| 11 |
33631374 | Intestinal α1-2-Fucosylation Contributes to Obesity and Steatohepatitis in Mice. | 2021 |
1 |
| 12 |
33783283 | Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling. | 2021 Dec |
2 |
| 13 |
33965587 | Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis. | 2021 |
5 |
| 14 |
34076007 | Leaf extract from Vitis vinifera L. reduces high fat diet-induced obesity in mice. | 2021 Jul 21 |
1 |
| 15 |
34164827 | Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor Signaling. | 2021 Nov |
2 |
| 16 |
34362888 | Intestinal-derived FGF15 protects against deleterious effects of vertical sleeve gastrectomy in mice. | 2021 Aug 6 |
1 |
| 17 |
34585527 | Bile acid metabolism dysregulation associates with cancer cachexia: roles of liver and gut microbiome. | 2021 Dec |
1 |
| 18 |
31206730 | Direct and Indirect Effects of Fibroblast Growth Factor (FGF) 15 and FGF19 on Liver Fibrosis Development. | 2020 Feb |
2 |
| 19 |
31645370 | Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition. | 2020 Jan |
1 |
| 20 |
32116693 | Naturally Occurring TPE-CA Maintains Gut Microbiota and Bile Acids Homeostasis via FXR Signaling Modulation of the Liver-Gut Axis. | 2020 |
2 |
| 21 |
32259714 | Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor. | 2020 Apr |
6 |
| 22 |
32404932 | Enhanced alcoholic liver disease in mice with intestine-specific farnesoid X receptor deficiency. | 2020 Sep |
3 |
| 23 |
32639145 | Teneligliptin Promotes Bile Acid Synthesis and Attenuates Lipid Accumulation in Obese Mice by Targeting the KLF15-Fgf15 Pathway. | 2020 Aug 17 |
1 |
| 24 |
32681035 | An FGF15/19-TFEB regulatory loop controls hepatic cholesterol and bile acid homeostasis. | 2020 Jul 17 |
4 |
| 25 |
32967428 | Assessment of the role of FGF15 in mediating the metabolic outcomes of murine Vertical Sleeve Gastrectomy (VSG). | 2020 Sep 23 |
2 |
| 26 |
33107729 | Naringin Alleviates Atherosclerosis in ApoE-/- Mice by Regulating Cholesterol Metabolism Involved in Gut Microbiota Remodeling. | 2020 Nov 11 |
1 |
| 27 |
33144503 | Curtailing FGF19's mitogenicity by suppressing its receptor dimerization ability. | 2020 Nov 17 |
5 |
| 28 |
33235221 | Intestinal FGF15/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A. | 2020 Nov 24 |
2 |
| 29 |
30387017 | A 19F magnetic resonance imaging-based diagnostic test for bile acid diarrhea. | 2019 Feb |
2 |
| 30 |
30679232 | Therapeutic FGF19 promotes HDL biogenesis and transhepatic cholesterol efflux to prevent atherosclerosis. | 2019 Mar |
1 |
| 31 |
30996006 | Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis. | 2019 May 31 |
7 |
| 32 |
31201556 | Targeting FXR in Cholestasis. | 2019 |
3 |
| 33 |
31254596 | Obeticholic acid may increase the risk of gallstone formation in susceptible patients. | 2019 Nov |
1 |
| 34 |
31767164 | The anti-obesity effect of FGF19 does not require UCP1-dependent thermogenesis. | 2019 Dec |
6 |
| 35 |
31920680 | Paracrine Fibroblast Growth Factor 1 Functions as Potent Therapeutic Agent for Intrahepatic Cholestasis by Downregulating Synthesis of Bile Acid. | 2019 |
1 |
| 36 |
32694803 | Metabolic Messengers: fibroblast growth factor 15/19. | 2019 Jun |
1 |
| 37 |
29159825 | Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice. | 2018 Jun |
2 |
| 38 |
29290621 | A gut-brain axis regulating glucose metabolism mediated by bile acids and competitive fibroblast growth factor actions at the hypothalamus. | 2018 Feb |
3 |
| 39 |
29295820 | Diet1, bile acid diarrhea, and FGF15/19: mouse model and human genetic variants. | 2018 Mar |
1 |
| 40 |
29672888 | Fibroblast Growth Factor 15-Dependent and Bile Acid-Independent Promotion of Liver Regeneration in Mice. | 2018 Nov |
2 |
| 41 |
29876009 | Diminished gallbladder filling, increased fecal bile acids, and promotion of colon epithelial cell proliferation and neoplasia in fibroblast growth factor 15-deficient mice. | 2018 May 22 |
3 |
| 42 |
30124818 | Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives. | 2018 Dec 1 |
1 |
| 43 |
30247920 | Attenuated Accumulation of Novel Fluorine (19F)-Labeled Bile Acid Analogues in Gallbladders of Fibroblast Growth Factor-15 (FGF15)-Deficient Mice. | 2018 Nov 5 |
7 |
| 44 |
30464200 | Suppression of Hepatic Bile Acid Synthesis by a non-tumorigenic FGF19 analogue Protects Mice from Fibrosis and Hepatocarcinogenesis. | 2018 Nov 21 |
11 |
| 45 |
28041926 | Chronic Over-expression of Fibroblast Growth Factor 21 Increases Bile Acid Biosynthesis by Opposing FGF15/19 Action. | 2017 Feb |
2 |
| 46 |
28065787 | Intestinal Farnesoid X Receptor Controls Transintestinal Cholesterol Excretion in Mice. | 2017 Apr |
2 |
| 47 |
28119353 | Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration. | 2017 Oct |
1 |
| 48 |
28130274 | Commensal bacteria at the crossroad between cholesterol homeostasis and chronic inflammation in atherosclerosis. | 2017 Mar |
1 |
| 49 |
28178326 | Quantitative liver proteomics identifies FGF19 targets that couple metabolism and proliferation. | 2017 |
2 |
| 50 |
28189755 | Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15. | 2017 Jun |
2 |